Genome Biology

Go back or start search again

Genome Biology

General information ?

Published by:

BioMed Central

ISSN:

1474-760X

Last checked date:

03/2020

Scope:

Genome Biology covers all areas of biology and biomedicine studied from a genomic and post-genomic perspective. Content includes research, new methods and software tools, and reviews, opinions and commentaries. Areas covered include, but are not limited to: sequence analysis; bioinformatics; insights into molecular, cellular and organismal biology; functional genomics; epigenomics; population genomics; proteomics; comparative biology and evolution; systems and network biology; genome editing and engineering; genomics of disease; and clinical genomics

Additional free text:

Co-submissions to other BMC ‘flagship’ journals. If a paper is potentially appropriate in scope for Genome Biology and either Genome Medicine or BMC Biology, authors have the opportunity to submit a manuscript for joint consideration at two of these journals at the same time. For a paper to be considered as a co-submission, the authors should upload their manuscript to one of the two journals and note in their cover letter that they would like a co-consideration with the second journal. Each journal will evaluate the paper independently. If both journals decide to send the paper for review, the editors will select reviewers together for a peer review process that evaluates the manuscript for both journals, and will make independent decisions based on reviewers’ feedback. Website Instructions for authors

Subject?

Main subject area:

Biology

Breadth of subject area:

Top level subject

Peer review?

Peer review type:

Conventional

Peer review openness:

Reports published anon

Selectivity:

Selective (IF ~8-15)

Open access?

Free to read option:

Paper can be free for anyone to read

Allows green OA:

Not applicable as gold

Has waivers:

Yes

Has membership system:

Institutional membership

Access type:

Full gold

Licence:

All papers are CC BY

Level of APC:

Over $4500

Speed?

Speed to first decision:

Unknown

Speed from acceptance to publication:

Unknown

Other?

Ownership of publisher:

Company

Length restrictions:

None

Provides altmetrics:

Altmetric

CrossMark implemented:

Yes

Has a 2015 impact factor:

Yes

Copyedits:

Yes